We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 161.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/5/2013 14:08 | I brought into CLL again on release of the full year results in March, the statement seemed to indicate that a strong recovery was underway, after the restructering undertaken in the previous year. My view was strengthened when both the FD and CEO purchased more shares after the results. So as long as the AGM statements confirms that the strong performance from Q4 has continued into this financial year, I would be happy to increase my holding again. By lack of posts here and comments elsewhere, it would seem that the improved trading hasn't been picked up yet. ic2... | interceptor2 | |
08/5/2013 13:18 | Glad you guys brought this to my attention, was wondering when agm was this month.....dyor but looks like 14 may from web-site.....good to have been able to buy the dips.....any other thoughts? | qs9 | |
07/5/2013 22:25 | I also have held CRE before, but took them off my watchlist in July 2012 after they disappointed me once too often. Can't say that I have seen any news since that has made me look at them in more detail. I seem to remember some option awards to directors, that were based on UK GDP figures, wasn't impressed by that at the time. ic2... | interceptor2 | |
07/5/2013 18:21 | Lets just say i much prefer CLL over CRE. I have held CRE in the past but it never did perform how i had hoped. | cfro | |
07/5/2013 17:15 | ic2, cfro - How do you think this stacks up against Creston? The latter screens well but I have not bought any because of my long held position here. | hpcg | |
07/5/2013 15:13 | Thinking the exact same things as you ic2, as particulary after the CEO bought i should have also bought more then but i was waylayed at the time buying/selling other stuff and didnt seem to get round to it. I have rectified the situation today tho. | cfro | |
07/5/2013 13:40 | When the FD brought at 47p and then the CEO at 50.78p, I was a bit slow to react. I was only holding my initial investment and should have brought more, so happy to have another chance. The situation now reminds me of May 2010, when I first brought in here at 34p, directors soon brought stock just below at 32p, and as trading continued strongly through 2010, the share price almost doubled within a year, before falling back again during 2011. ic2... | interceptor2 | |
07/5/2013 11:53 | Looks a good price to buy in at ic2 imo. Very quiet bb and quiet share price too. Its funny that it had crossed my mind to think about another top-up myself. | cfro | |
07/5/2013 11:03 | CLL historically issues an AGM statement between 15th to 17th May, so we should see one next week between Wednesday to Friday or the following Monday? I did purchase some more this morning and will look for confirmation within the AGM statement, that the strong turnaround reported at the full year reults in March, is continuing. Didn't think I would have a chance to buy at a level close to the FD or below the CEOs recent purchase. ic2... | interceptor2 | |
19/4/2013 11:23 | Interested to see who bought 2% of the company yesterday. | coopstock | |
19/4/2013 08:15 | Product launch from FACE one of CLL's divisions. "Having doubled the size in the past 12 months with offices in New York, Singapore and Hong Kong, Pulsar TRAC is the first in a series of planned product releases from face which marks an evolution of the business from a research agency to a technology driven consultancy". | cfro | |
09/4/2013 08:27 | With both the FD and now the CEO buying shares, it sounds like the strong momentum reported last month, is continuing into the new financial year. ic2... | interceptor2 | |
09/4/2013 07:59 | CEO share purchase. | cfro | |
22/3/2013 10:49 | Up again today. Forward pe is still around seven. | cfro | |
20/3/2013 15:56 | On a breakout now.... | cfro | |
20/3/2013 15:06 | Must be using an internet broker - a straight buy order tends not go inside the spread. However given the other trades today one would think that they left 5% on the table. It wouldn't surprise me if we find out it was another officer. | hpcg | |
20/3/2013 14:46 | sp increasing further now with more buyers arriving, someone just paid 50p for 10k. Either CLL shares are about to rise further, or he needs a new broker. ic2... | interceptor2 | |
20/3/2013 08:34 | Very good news You may remember cfro because I think you were holding at the time, the last time M Bently brought share was June 2010 at 32p, the share price doubled within 7 months that time :o) That time the Chairman and CEO brought on the same day, but the CEO has been buying recently. ic2... | interceptor2 | |
20/3/2013 07:56 | Thanks for the article IC2. FD bought a few @47p. :-) | cfro | |
15/3/2013 16:38 | Thats an unexpected move, nice....:-) | cfro | |
14/3/2013 13:39 | With the restructuring completed into two focused operating sectors now, Cello Health and Cello Consumer, I had the feeling reading yesterdays results, that they have turned the corner now and were sounding more confident about the future. Cello Health continued it's strong performance from Q4 into the new financial year, and Cello Consumer has made a good recovery. International business has now increased to 46.1% of revenue, with a good increase seen in the USA and Asia Pacific, in 2009, International revenue was only 22.4%. Also pleased to see the dividend increased 17%, they now yield 6%. I need to see the gap closing between reported earnings and adjusted earnings, the four adjusted figures I think that should either disappear or significantly reduce now are, restructuring costs, Impairment of goodwill/intangibles The board sound much more upbeat now, in the 2011 full year statement they said "At this early stage of the year the Board is optimistic that current expectations for 2011 can be met". In 2012 they used the same sentence to sum up expectations, but yesterday the said "Board is confident that current year expectations will be met" As long as the stronger growth from Q4, which has continued into 2013 continues through out the year, then I would hope this may be a good time buy back in. They were on a PER for 2013 of 6.65, so I will await new estimates with interest. ic2... | interceptor2 | |
14/3/2013 10:19 | Very wierd coincidence ic2! :0)) | cfro | |
14/3/2013 09:12 | That's a coincidence I was thinking along the same lines :o) I did take a small position yesterday in case they have turned the corner now. ic2... | interceptor2 | |
14/3/2013 09:08 | No comments on yesterdays results means these are somewhat neglected. They might be turning a corner now tho with a bit of luck. | cfro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions